{"version":"1.0","provider_name":"Cilcare","provider_url":"https:\/\/www.cilcare.com\/jp","title":"CILcare receives grant from the Occitanie Region to conduct research into potential ototoxic effects of investigated drugs for Covid-19 - Cilcare","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"aU1CfEizsD\"><a href=\"https:\/\/www.cilcare.com\/jp\/2021\/01\/05\/grant-covid-19-covidototox\/\">CILcare receives grant from the Occitanie Region to conduct research into potential ototoxic effects of investigated drugs for Covid-19<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.cilcare.com\/jp\/2021\/01\/05\/grant-covid-19-covidototox\/embed\/#?secret=aU1CfEizsD\" width=\"600\" height=\"338\" title=\"&#8220;CILcare receives grant from the Occitanie Region to conduct research into potential ototoxic effects of investigated drugs for Covid-19&#8221; &#8212; Cilcare\" data-secret=\"aU1CfEizsD\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.cilcare.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>","thumbnail_url":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2021\/01\/Illustration-Covidototox-Site-web-e1609854890761.png","thumbnail_width":1000,"thumbnail_height":590,"description":"Montpellier, January 5th, 2021: CILcare, the world-leading CRO specialized in auditory research, is announcing the launch of its COVIDOTOTOX research project. Subsidized by the Occitanie Region at 87k\u20ac, the COVIDOTOTOX project aims to assess the potential side effects on the inner ear of some investigated drugs for the SARS-CoV-2 virus. In the frantic race for a coronavirus cure and based on available data attesting to significant ototoxic effects of chloroquine, CILcare is launching its COVIDOTOTOX project. This project places CILcare at the forefront of the mission to find safe treatment for Covid-19. Chloroquine and hydroxychloroquine, which have been used to prevent or treat malaria for years, have been explored as [&hellip;]"}